Alfa Chemistry Commenced Offering PTFE (Polytetrafluoroethylene), Optical Fibers, and Diamond Raw Materials

Startup OncoDxRx harnesses the power of proprietary liquid biopsy technologies for better clinical diagnostics and therapeutics

New Startup OncoDxRx showcases its one-of-a-kind Dx technologies for oncology market

Creative Enzymes Offers Personalized and Customized Probiotic Blends

Creative Enzymes Introduces Cloning Enzymes for Molecular Biology Research

Oxygen-, Nitrogen-, Carbon-Donor Ligands for Coordination Chemistry Research

Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines

Alfa Chemistry Celebrates Thanksgiving Day and Christmas with Festival Sale for All Products and Services

API Supply Enriched by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

Nearly 480 Cosmetic Ingredients Are Now Available at CD Formulation

Blue Spark Technologies Touts Growth for Company and Remote Patient Monitoring Industry

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, celebrated a successful year of achievements with its continuous temperature monitoring solution TempTraq®. Numerous studies were released this year showing the positive impact of TempTraq in oncology clinical trials and outpatient settings.

Energy reduction measures including AI are now needed to avoid energy shortage in 2023!

Arloid Automation welcomes the new partnership between the UK and the USA (announced December 2022) to drive down energy prices but really it’s a reduction in energy consumption that’s needed to meet demand in 2023.

Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma.

One-Of-A-Kind Test That Targets the Majority of Cancer Population Currently Not Qualified for Precision Medicine

OncoDxRx scientists has described the combination of NGS and PGA as ‘world beating’ offering that will complete the test menu and benefit entire population of cancer patients.

HighTide Therapeutics and Quotient Sciences Announce Agreement to Conduct a 14C Human ADME Program for HTD1801

Integrated Synthesis-to-Clinic® Program Will Support HTD1801’s Clinical Development and Regulatory Submission Package

NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture

New evidence demonstrates that NoriZite creates a physical barrier to prevent viral infection

physIQ’s eVO2Max™ demonstrates breakout ability to estimate cardiopulmonary functional capacity from wearable sensor data during daily routine activity

physIQ today announced a novel approach to estimating maximum oxygen utilization (VO2Max) using wearable biosensors and deep neural network technology. This innovative biomarker, eVO2Max, can be generated using 24 hours of continuous vital signs and activity data captured during routine daily activities. This enables remote assessment at higher frequency and convenience than by in-clinic tests of cardiopulmonary functional capacity, such as the gold standard, cardiopulmonary exercise test (CPET), and the less accurate surrogate six-minute walk test (6MWT).

PubHive Upgrades Life Science Literature Workflow SaaS Platform

PubHive Navigator’s Fetch version 2.0 features new content curator and consumer roles, expanded data input and output options, integration capabilities, plus a simplified consumer user interface

Form Bio Brings Accelerated Genomic Analysis to Bioinformatics with NVIDIA Clara Parabricks

Form Bio, the breakthrough computational life sciences platform, today announced the integration of the NVIDIA Clara Parabricks suite of genomic analysis tools with Form Bio’s genomic analysis workflows. The integrated solution, provided by Form Bio, enables scientists, bioinformaticians and other life science professionals to execute genomic workflows with acceleration fueled by GPU parallelization and deep learning AI tools.

Vaxess Announces Interim Results from Phase I ClinicalTrial of MIMIX-Flu Vaccine Patch

Company focused on creating shot-free future of vaccines and expanding vaccine access; first human trial of Vaxess patch-based influenza vaccine showed strong safety and immunogenicity profiles

InSysBio to release Immune Response Template for QSP modeling in Oncology

InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.